Kinetix Systems Holdings Limited (8606.HK)
Kwun Tong, HK
Kinetix Systems Holdings Limited operates as an investment holding enterprise, specializing in offering a wide array of information technology (IT) services across Hong Kong and Macau. The firm's activities are structured into four key segments: IT Infrastructure Solutions, IT Development Solutions, IT Maintenance and Support Services, and Entertainment Products. For IT infrastructure, Kinetix advises clients on essential hardware and software needs, subsequently sourcing these components from authorized distributors or third-party vendors and integrating them seamlessly into clients' existing IT systems. Additionally, the company delivers IT development solutions, which include system analysis, design, custom software creation, and technology consultancy. It also furnishes comprehensive IT maintenance and support services. Beyond its core IT operations, Kinetix also runs an e-commerce platform for entertainment products and extends human resources services. Serving a diverse clientele, it supports both private and public sector organizations, encompassing government bodies, financial institutions, technology, media, and telecom enterprises, as well as transportation and logistics companies. Established in 1998 and headquartered in Kwun Tong, Hong Kong, Kinetix Systems Holdings Limited operates as a subsidiary of Vigorous King Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -5.08% | +0.00% | -21.13% | -12.50% | -13.85% | -41.05% | -65.85% | -93.09% | -92.00% | -92.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Information Technology Services: +10.1%+17.2% ★ Q4'25: +15.0% (vs Q4'24)
-
EPS growth Information Technology Services: +16.7%+151.5% ★ Q4'25: +100.0% (vs Q4'24)
-
FCF margin FCF growth · Information Technology Services: +32.8%+5.1% ★ Q4'25: +16.6% (vs Q4'24)
-
EBIT margin Information Technology Services: +9.0%+0.9% Q4'25: +0.4% (vs Q4'24)
-
ROIC Information Technology Services: +9.5%+12.7% ★ Q4'25: +4.7% (vs Q4'24)
-
Share dilution Information Technology Services: +0.0%+0.0% Q4'25: +0.0% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Information Technology Services: -0.83×2.52× ★ Q4'25: 5.34× (vs Q4'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-15 | B- | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | B- | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | B- | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | B- | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | B- | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | B- | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-27 | B- | 2/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | B- | 2/5 | 5/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Larry Yu | Executive Chairman of the Board & Chief Executive Officer | 2M | male |
| Cheong Yu Leung | Compliance Officer & Executive Director | 1M | male |
| Cheung Moon | Senior Project Manager of Professional Service Team & Executive Director | 810.0K | male |
| Kui Kei Fung | Company Secretary | — | male |
| Tai Wai Lam | Chief Operating Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 8606.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
